Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
A. D. Adema(Amsterdam UMC Location Vrije Universiteit Amsterdam), Godefridus J. Peters(Gdańsk Medical University), Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Marit Liland Sandvold, Henk M.W. Verheul(Erasmus MC Cancer Institute)
Cited by 27
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795